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I have no idea if this short account will be of 
any interest to others but in writing it I have a 
strong sense of good fortune for having had the 
career I have had as a neuropathologist. 
My interest in joining the medical profession 
emerged in my teens and I found myself in 1960, at 
the age of 18, commencing a degree in Physiology 
at St Hugh’s College, Oxford University, as the first 
stage towards attaining this ambition. This 3-year 
course was to be followed by three years of clinical 
training and a supervised year of hospital practice 
before full registration as a medical doctor. Women 
made up about 10% of the medical students at 
Oxford at that time and, in due course, we were 
distributed in a wide range of medical specialties. 
The early stages 
My professional development was complicat-
ed by meeting and marrying a fellow medical stu-
dent from Nigeria and embarking on bringing up a 
family while still a clinical student. This influenced 
my choice of specialty because it was almost im-
possible to specialise part-time and front line clini-
cal specialties demanded very long hours of train-
ing which would have been incompatible with 
bringing up a family. Therefore, after completing 
my clinical studentship, I took up a scholarship 
from the UK Medical Research Council to have 
training in research methods as the next stage of 
my education. The training was undertaken under 
the supervision of Professor Graham Weddell in the 
Department of Anatomy. My brief was to spend a 
year learning the relatively new technique of elec-
tron microscopy and applying it to a study of dis-
eased muscle in mice which had been infected with 
the leprosy bacillus, Mycobacterium leprae, after 
being immunosuppressed by whole body irradia-
tion. Graham Weddell was an elderly, avuncular 
character with a kind but rather vague air. He was 
an expert in the structure of peripheral nerves, a 
site that the leprosy bacillus was known to damage. 
By reducing the immune response to the bacillus by 
subjecting the experimentally infected mice to irra-
diation, it was thought that light might be cast on 
how nerves were damaged in the naturally occur-
ring human disease. 
This was a completely new field of endeavour 
for me. I knew nothing about electron microscopy, 
nor leprosy, nor muscle. My first task was to learn 
how to prepare the tissues, sent to us from a col-
laborating laboratory in London, for light and elec-
tron microscopy. There were other people in the 
laboratory who were using the electron microscope 
for other purposes and they could share their ex-
pertise with a newcomer such as myself. It took 
some time to become familiar with the hugely 
magnified features of the cells being examined with 
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the electron microscope – it was another world 
that was being displayed before one’s eyes. I went 
to the books and scientific papers to get help in 
deciphering the images I was seeing. I had never 
felt so much need to follow every letter of the mes-
sage in papers and books about these ultrastruc-
tural features. My attention was much more rivet-
ed on what I was reading than it had been when I 
was reading papers for my tutorials as an under-
graduate. Now the details were needed to help me 
make sense of what I could see. 
 
Fig. 1. Mycobacterium leprae in muscle 
Colony (C) of Mycobacterium leprae in a foot-pad striated-
muscle fibre. The bacillary membranes can be clearly distin-
guishedinthose sectioned transversely. The organisms are lying 
freely in a sarcoplasmic matrix. Myofibrils (mf) and mitochon-
dria (M) are also present. Thymectomised-irradiated mouse 
given 107 Myco. leprae i.v. 11 mth previously. UA, LC, EM 
x36,000. 
published with permission from Esiri MM et al. 1972; 106: 73-
80. 
Some of the muscle samples that I studied had 
been prepared for examination using a light micro-
scope. This was to enable me to get more of a 
‘bird’s eye’ view of what I was studying under the 
electron microscope. I was frustrated to find that 
for quite a long time I could not find any leprosy 
bacilli in my electron microscope preparations de-
spite the fact that I could clearly see clusters of 
them with the light microscope. This happened 
because the tissue samples used for electron mi-
croscopy were tiny compared with those viewed 
with the light microscope and it was easy to miss 
such minute structures as bacilli. I began to wonder 
if I would ever find any bacilli at the ultrastructural 
level, but then came a red letter day when a whole 
cluster of them, appearing large and black, were 
suddenly there in front of me in a new sample of 
tissue (Fig. 1). I fell on them, photographing them 
with abandon to preserve a record of their struc-
ture and their localization in the muscle fibres. 
For the electron microscopy work I clearly 
needed to be present in the Anatomy Department 
but for the light microscopy I was given the loan of 
a microscope to take home so that some of my 
work could be carried on there at times that were 
the most convenient to me. It was typical of Gra-
ham Weddell that he went out of his way to enable 
my work to fit in with my home life. From time to 
time we would have a discussion about the work so 
that he could satisfy himself that it was progressing 
satisfactorily but most of the time he just left me to 
get on with it. In due course I wrote a short thesis 
and we prepared a paper describing our findings 
which was submitted to a scientific journal. 
I was aware as I carried out my practical work 
in the Anatomy Department that Professor Weddell 
had regular visits from someone from the local 
teaching hospital, the Radcliffe Infirmary, who 
wished to familiarise himself with the electron mi-
croscopy of muscle and nerve. He wished to be 
able to extend to the ultrastructural level the ex-
amination he made of muscle and nerve biopsies 
from patients that were taken for diagnostic pur-
poses. His name was Dr Trevor Hughes (Fig. 2) and 
he worked at the Neuropathology Department of 
the Radcliffe Infirmary. Trevor told me that he was 
hoping to obtain funds to support a Junior Re-
search Officer post in his department that would be 
devoted to muscle disease research. Would I be 
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interested in applying? I explained that I needed to 
obtain my full General Medical Council registration 
by occupying a year of preregistration House Of-
ficer posts, but we agreed to keep in touch. 
 
Fig. 2. Dr J Trevor Hughes 
 
While I was carrying out this year of leprosy 
research, I had kept my hand in at dealing with 
patients by helping out once a week in an endocri-
nology clinic run by one of the consultants, Dr 
Derek Hockaday, whose clinical firm I attended for 
my second medical attachment as a student. Derek 
was aware of my difficulty in obtaining pre-
registration house jobs while responsible for a 
young family. It was necessary to obtain the full 
GMC registration to enable me to progress to any 
subsequent clinical specialty. Derek was sympa-
thetic to my plight. He had a wife who worked part-
time as a paediatric neurologist and they had 3 
young children. He eventually offered me a super-
numerary pre-registration house job that would 
not pay me but would give me the experience nec-
essary to secure full registration. This dealt with the 
6 months’ medical experience. To complete the 
additional 6 months’ surgical experience that I 
needed, I managed to gain approval to work as a 
House Officer in Obstetrics, a specialty that did not 
have routine pre-registration jobs. The advantage 
of taking this route was that it entailed a 1-in-3 on 
call rota at night, whereas in surgery this rota 
would have been 1-in-2. It was also critical that I 
had the offer of such an obstetric post from the 
head of the Obstetric service, Professor John Stall-
worthy, whereas none of the surgeons was willing 
to offer me a post. Thus, I had secured the possibil-
ity of getting my full medical registration, albeit 
with an unconventional set of posts. I also needed 
to secure the home situation and here we were 
very lucky to find a very good young nanny, Jenny, 
who was willing to live in so that I could do my 
nights on call. I enjoyed this year of clinical work 
but I knew it would be impossible for me to carry 
on with this type of work in the future. 
At the end of the year, I therefore applied for, 
and obtained, the Junior Research Officer post that 
Trevor Hughes had secured. The post was for 3 
years and it would enable me to work for a DM 
research degree while allowing me at the same 
time to see what I thought about a career in Neu-
ropathology. I recognised that this was a very small 
specialty with only about 20 departments in the UK 
and those confined to major medical centres. I had 
always kept at the back of my mind the possibility 
that I might end up working in Nigeria. If I trained in 
Neuropathology I would need to re-train if I were 
going to Nigeria. But since our young family had 
appeared, Nigeria had been experiencing a bloody 
civil war, ruling it out for settling in for the time 
being. The prospect of three further years living 
and working in Oxford helped us to decide that it 
would be best if the children were to be brought up 
with their roots in the UK. We did not think it 
would be a good idea to move the children to and 
fro between Nigeria and the UK even if the civil war 
had ended. 
So, in 1970, I started as a Junior Research Of-
ficer in Neuropathology. I needed to decide on a 
topic to research on muscle disease. Perusal of the 
textbooks about human muscle disease seemed to 
suggest that although there was a great variety of 
rare diseases, the two categories of disease that 
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were more common were inflammatory myopa-
thies and muscular dystrophies. I chose to study 
inflammatory myopathies because I had become 
interested in the role of the immune system in dis-
ease during my experience of studying leprosy. 
There were also not then the tools readily available 
to carry out genetic studies of muscular dystrophy 
that are now very effectively in play. 
Inflammatory myopathies can occur at any 
age but are most common in late middle age. To 
make a definitive diagnosis, a small sample of mus-
cle – a biopsy – needs to be removed and studied 
under the microscope to see if inflammation is 
present. The cause of the inflammation is not cer-
tain but it was thought likely that it was due to an 
immune reaction to some component of muscle, 
triggered by division and activation of subsets of 
lymphocytes. I decided to investigate blood lym-
phocytes taken from people with recently diag-
nosed inflammatory myopathies and compare their 
reactions in culture to a small concentration of 
homogenised muscle with the reactions of healthy 
people (myself and my colleagues). To do this I 
needed to find an immunology laboratory that 
could accommodate me and my lymphocyte cul-
tures. There was such a laboratory in the Nuffield 
Department of Medicine. It was headed by Dr Ian 
McLellan. Although the laboratory was already full 
of researchers, he very generously allowed me to 
join them. I carried out my human lymphocyte 
studies there and also studied rats in which I at-
tempted to produce a similar condition of inflam-
matory myopathy by injecting them with muscle 
homogenate combined with an adjuvant. While the 
lymphocytes were being cultured, I also examined 
the muscle biopsies from the same patients with 
light and electron microscopy. Although there 
would be no foreign organisms expected to be pre-
sent in the muscle if this inflammatory myopathy is 
an autoimmune disease, it still seemed worthwhile 
to check for any invading organisms, such as virus-
es, which might be detectable with an electron 
microscope. To start with, I used the electron mi-
croscope in the Anatomy Department that I was 
already familiar with but the Radcliffe Infirmary 
soon acquired one of its own in the Pathology De-
partment where it was particularly useful in diag-
nosing the nature of kidney disease from studying 
renal biopsies. I was able to use this electron mi-
croscope soon after it was installed and it turned 
out to be very useful for diagnosing some of the 
rare muscle diseases. 
Just as I had initiated these studies and satis-
fied myself they were running well, I was overtaken 
by an unexpected event – a massive fire in March 
1971 that destroyed the whole of the Neuropa-
thology Department and the adjacent hospital li-
brary at the Radcliffe Infirmary. Luckily no one was 
injured. The fire occurred at night and I came in the 
next morning to find the department, including all 
my records, razed to the ground. The hospital au-
thorities had to scurry round searching for some-
where to put us. The Professor of Surgery gener-
ously offered an office and there was some recent-
ly vacated animal house accommodation, rather 
dark and damp, into which we could move.  Having 
scavenged a few chairs and a desk or two from 
sympathetic colleagues, we sat ourselves in the 
animal house to draw breath when who should 
appear but a former neuropathologist who had 
moved a few years earlier to London, Dr Sabina 
Strich. She had heard the news of the fire on the 
radio and promptly come to visit and commiserate 
and to provide us with a new electric kettle, mugs, 
coffee and chocolate wholemeal biscuits. It was 
such a welcome gesture! It raised all our spirits and 
made us determined to make the best of the situa-
tion. Fortunately, my lymphocyte studies could 
continue in the Immunology Laboratory which was 
in a different part of the hospital, even though the 
records of the first experiments were lost. There 
were also negatives from the electron microscope 
studies that could be retrieved and reprinted. Some 
of the brain specimens from earlier years were still 
retained in a hut in the grounds of another hospital 
and those that were most instructive for teaching 
purposes were retrieved and sections re-cut for 
microscopy. Some second hand equipment such as 
microscopes and microtomes, needed to cut thin 
sections, were rapidly acquired and the elements of 
a re-formed department thus assembled. Eventual-
ly the whole destroyed floor of the hospital was re-
built, though this was not to happen for several 
years. 
The three years of the junior research officer 
post passed quickly with my energies divided be-
tween the laboratories and the home. We now had 
a new nanny, Jane, who stayed with us until all the 
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children were at full time school. The combination 
of research and pathology was much more compat-
ible with family commitments. My husband was 
pursuing a surgical training and holding a succes-
sion of short term posts all over the country as was 
the usual practice in those days. He returned home 
whenever he was able to. 
The lymphocyte studies yielded modest evi-
dence of lymphocyte sensitivity to muscle in in-
flammatory myopathies. It was not a dramatic ef-
fect and could have been the result, rather than the 
cause, of the condition. It was difficult to provoke 
any more than a slight inflammatory reaction in the 
muscle of the sensitised rats. In the electron micro-
scopic studies, there was only one biopsy that con-
tained what might have been virus-like particles. 
Thus, the fruits of my studies were far from conclu-
sive. I believe it remains the case today, more than 
40 years after these studies were performed, that 
inflammatory myopathies are really little better 
understood. However, the thesis I wrote describing 
these studies earned me a DM degree and I pub-
lished a couple of papers summarising the findings. 
I had found satisfaction from this work but now felt 
increasingly curious about the central nervous sys-
tem and its diseases that I had started to become 
familiar with. However, before I was certain that 
neuropathology should become my chosen special-
ty, I needed to become familiar with other branch-
es of pathology as part of my training. 
What did these two short periods of research 
teach me? First they reinforced my admiration for 
science. I particularly admired the way science was 
prepared to embrace the contributions of people 
wherever they came from and whatever their 
background provided they worked with integrity 
and had innovative ideas. I admired the way sci-
ence relied on reproducibility of findings to give 
them credence and not on the advertising ability of 
their perpetrators to give validity to their findings. I 
came to appreciate the importance of Karl Popper’s 
dictum that scientists should seek to refute their 
ideas, not confirm them. Scientific ‘facts’ are al-
ways provisional and can be revised if subsequent 
experiments are incompatible with them. I learnt to 
recognise the importance of quantitation in record-
ing results of experiments and the need, in studying 
disease, to include control samples as well as sam-
ples from the disease under investigation. It was 
important for the investigator, whenever possible, 
to be unaware of which samples were from con-
trols and which from disease so that there was no 
chance of bias creeping into the observations being 
made. It seemed to me that if careful quantitative 
studies were performed they could almost always 
yield useful information even if they showed that 
the ideas that prompted the experiments turned 
out to be incorrect. In short, science satisfied my 
urge to ask questions and seek answers to them 
and having commenced my efforts in that direction 
I was going to continue if I could. 
The next stage 
To become a neuropathologist in the 1970s I 
needed first to gain experience of other specialties 
of clinical pathology. I became a trainee registrar 
with a post that rotated through haematology, 
bacteriology, virology and histopathology. The 
longest time (2 years) was spent in histopathology 
(also known as cellular pathology). There were ex-
ams to take for membership of the Royal College of 
Pathologists once the practical experience had 
been obtained. It was essential to gain this qualifi-
cation before applying for a post as consultant in 
the NHS. The exam had a heavy component of his-
topathology, hence the longer time spent in that 
specialty. 
I didn’t find the haematology or bacteriology 
very interesting. The numbers of samples to be 
analysed in each of these departments were so 
overwhelming that much of the work had been 
automated. Many samples would typically be sent 
to each of these departments during the course of 
each patient’s hospital admission and, in addition, 
many samples were sent in each day from local 
general practitioners. The departments were pri-
marily concerned with delivering a diagnostic ser-
vice and there was relatively little that I, as a new-
comer, could contribute. They did not undertake 
active research. Histopathology was of greater in-
terest, being more directly relevant to neuropa-
thology. I learnt how to perform post mortem ex-
aminations (in the process giving myself the only 
nightmares I’ve ever had, in which the corpse came 
to life while I was busy and I attempted to replace 
the larynx so that it could speak!) and to report on 
surgical specimens of tissue. Because of the large 
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variety of specimens and of the conditions they 
exhibited, it took a fair time to be able to make 
correct judgements on the nature of the disease, 
often cancer. Samples were examined under the 
microscope, first by myself and then by a consult-
ant who was able to share his or her experience 
and pass on to me the critical visual clues that 
yielded the essential evidence about the nature of 
the disease process. 
The head of the Histopathology Department 
was Dr Robb-Smith, a slightly shy and enigmatic 
character whom I had encountered as a student at 
post mortem demonstrations. He was interested in 
attracting women to his specialty and had secured 
a trainee post that could be held part-time. This 
enabled me to have two free afternoons each 
week. I found the children were all occupied at 
these times so I used this time to write up my DM 
thesis, a task I had been putting off while I dealt 
with more immediate concerns at home and at 
work.  
One of the great advantages for me of work-
ing in the Histopathology Department was that I 
not only gained essential diagnostic experience but 
I was also able to participate in research. There was 
a research officer there, Dr Ian Burns, who was 
experimenting with the use of antibodies to detect 
specific proteins in tissue sections. If antibodies 
could be produced towards a purified protein of 
interest and tagged with a marker substance such 
as a coloured dye or a fluorescent dye, this could 
be used to detect specific proteins in tissue sec-
tions with much greater specificity than could be 
provided with the traditional tinctorial stains. This 
was the principle behind the work that Ian Burns 
was carrying out and which has now become the 
hugely successful branch of pathology, immuno-
histology or immunocytochemistry.  When Ian was 
working in the early 1970s, he was concentrating 
on the use of antibodies to detect immunoglobu-
lins, themselves antibody proteins produced by 
plasma cells. I was able to make use of Ian’s rea-
gents to study plasma cells containing different 
types of immunoglobulins in sections of central 
nervous system tissue affected by different diseas-
es.  
This was research I undertook when I had 
moved back from the Histopathology Department 
to be a registrar in the Neuropathology Depart-
ment. My experience in more general pathology 
had not seduced me into getting more interested in 
that field. Rather, I thought there were important 
things I had learnt there, particularly this new sub-
ject of immunohistology, that I could usefully apply 
in neuropathology. Back in the Neuropathology 
Department, I was also gaining experience of diag-
nostic aspects of the specialty by examining biop-
sies removed from brain tumours by the neurosur-
geons as well as other biopsies such as those from 
muscle and peripheral nerves. I was also perform-
ing post mortem examinations on cases of neuro-
logical disease and brain trauma. This diagnostic 
work I found still left time for a limited amount of 
research in which I applied the antibody techniques 
I had been lucky enough to learn about from Ian 
Burns to nervous system diseases. This was an ex-
ample of the wonderful way that collaboration can 
be developed in science and I was to become a 
great advocate of such collaboration, prizing it far 
above competition which, in some fields or de-
partments of medical science sadly seemed to pre-
dominate. 
I was lucky enough to obtain the modest funds 
needed to enable me to employ a technician to 
assist with the application of immunohistology in 
neuropathological material. I started by studying 
the lesions or areas damaged in the central nervous 
system in multiple sclerosis, most generally consid-
ered as an autoimmune disease1. This was a condi-
tion that was of interest to the other consultant in 
the Neuropathology Department, Dr David Oppen-
heimer (Fig. 3), who had written a DM thesis on it. 
He had seen many examples of this condition in 
post mortem studies and the tissues from some of 
these cases were still available in the department 
despite the fire that had destroyed much material 
in 1971. One of the beauties of the immunohisto-
logical technique was that it could be used on tis-
sue that had been preserved in the department 
after being fixed in formalin and then embedded in 
paraffin wax to enable thin sections to be cut. Alt-
hough some proteins that may be of interest in 
tissues are destroyed by such treatment, meaning 
that fresh frozen sections are needed to study 
them, there are many others that survive this 
treatment. The advantage of being able to use for-
malin-fixed, paraffin-embedded sections is that this 
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tissue shows better preservation of its structure 
than can usually be seen in frozen sections. 
 
 
Fig. 3. Dr David Oppenheimer 
 
I followed up the work on multiple sclerosis 
with studies of diseases that did have a foreign 
organism in the damaged tissues, starting with 
poliomyelitis of which we had cases dating from an 
epidemic of polio in the UK in the late 1950s. Later I 
extended the work to a study of cases of the rare 
complication of measles, subacute sclerosing 
panencephalitis. I wanted to know if these diseases 
showed a similar distribution of plasma cells con-
taining immunoglobulins as I saw in multiple scle-
rosis. Although this turned out to be the case, the 
difficulty in interpreting the significance of the find-
ing was that the arrangement of plasma cells might 
be just the same in autoimmune disease as in one 
with a foreign organism. While these studies were 
proceeding, more antibodies for use in immuno-
histology were being produced, including some 
directed to viruses. I was to make use of these for a 
later study when I was a Research Fellow. 
The Neuropathology Department when I 
joined it was a small one. There were 2 consultants, 
Drs Hughes and Oppenheimer, a registrar (myself), 
3 technicians and a laboratory assistant. Trevor 
Hughes had a particular interest in muscle disease 
and spinal cord disease. He had moved into neuro-
pathology from histopathology. David Oppenhei-
mer had a less conventional background. He had 
started his academic career with degrees in Philos-
ophy, Politics and Economics and also Music. Dur-
ing the Second World War, he had been a conscien-
tious objector and worked with an ambulance team 
in London rescuing injured people in the blitz. This 
experience awakened his interest in medicine and 
he read for his medical degree immediately after 
the war. Initially he worked on neuroanatomy and 
it was from there that he moved to neuropatholo-
gy. He was initiated into diagnostic work by his 
predecessor, Sabina Strich, over a matter of a few 
months. He recognised that his lack of experience 
in histopathology and other pathology specialties 
was a handicap but his knowledge of neuroanato-
my was most valuable. It made him particularly 
interested in the many important diseases of the 
nervous system in which there is a neuroanatomi-
cal basis for the way the disease is expressed or, in 
some cases, seems to spread. I had been intro-
duced to the Neuropathology Department by Tre-
vor Hughes but as time went on I became more 
interested in the conditions that interested David 
Oppenheimer, starting with multiple sclerosis. 
One of the first opportunities that arose from 
the diagnostic work that I carried out was a chance 
to study a rare case of herpes zoster (shingles) in an 
elderly woman who happened to die just after the 
eruption developed. It wasn’t the herpes zoster 
that killed her but an advanced state of multiple 
myeloma which had rendered her susceptible to 
developing herpes zoster. My patient had herpes 
zoster affecting the region supplied by part of the 
trigeminal nerve. Herpes zoster is caused by the 
same virus that causes chickenpox, varicella-zoster 
virus. The theory had been developed that in the 
natural history of infection with this virus, chicken-
pox is the first manifestation of infection. As the 
virus is overcome by the immune response that 
enables the person with chickenpox to recover, 
some virus survives and lies latent in the nerve cells 
of one or more sensory nerves. Circulating antibody 
which persists after recovery from chickenpox 
makes any reactivation of the virus uncommon 
until later in life when the level of antibody wanes 
or when the person has their immunity compro-
mised by disease. When the virus reactivates in the 
sensory nerve cells of a particular nerve, it travels 
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along the nerve to the skin where it causes the 
eruption of herpes zoster. Although this theory was 
widely accepted, the reactivation of the virus in 
nerve cells had never been demonstrated. It was 
this reactivation that I was able to show by electron 
microscopy which revealed the virus particles in the 
nerve cells of the trigeminal ganglion (Fig. 4). A 
colleague in the Virology Department, Dr Albert 
Tomlinson, carried out immunofluorescence using 
an antibody to the varicella-zoster virus on frozen 
sections of the ganglion and the nerve and was able 
to show the virus at both sites. 
 
Fig. 4. Herpes zoster viral particles in the cytoplasm (C) of a 
trigeminal ganglion neuron. 
From Esiri MM, Tomlinson AH J Neurol Sci 1982; 15(1); 35—48. 
 
The varicella-zoster virus that Dr Tomlinson 
was able to show in frozen sections of the nerve 
and ganglion of our case could not be seen when 
we tried to detect the virus in formalin fixed tissue 
– the viral protein was an example of an antigen 
that could not survive formalin fixation. This obser-
vation made me think that there could be more we 
could learn from our post mortem and surgical 
specimens if we thought carefully about whether 
we should preserve a portion of tissue by snap 
freezing it in liquid nitrogen and then storing it in a 
-70◦C freezer. Snap freezing in liquid nitrogen pre-
served the tissue structure better than slowly freez-
ing tissue in a freezer but only if the tissue sample 
was small. The opening of our minds to the poten-
tial importance of deep freezing some tissue was to 
prove important in years to come, not only to ena-
ble immunohistology to be performed for detection 
of antigens that were sensitive to formalin but also 
to enable biochemical and genetic studies to be 
carried out. It led to Oxford being early in the field 
of brain banking for research (for a history of brain 
banking in the UK see 2). 
The highly trained technicians that we worked 
with in neuropathology played an absolutely essen-
tial role in all that we did. Unlike in histopathology, 
where most tissue sample sections were subjected 
to a single stain, in neuropathology it was common 
to have consecutive thin sections from the same 
block of tissue stained with several different stains, 
some of which were quite difficult to perform. Each 
technician had their special expertise in carrying 
out a selection of these stains. Some were histo-
chemical stains that enabled enzymes to be dis-
played in frozen sections. These histochemical 
stains were mainly used on muscle biopsies. Each 
of the tinctorial stains picked out a particular fea-
ture of the nervous system to highlight. Nowadays 
the need for these special tinctorial stains is much 
reduced because immunohistology can convey the 
same information using antibodies that are more 
specific and more straightforward to apply. Some 
of the reagents used in the tinctorial reactions are 
quite toxic and it is far preferable that technicians 
can now avoid them. 
My closest colleagues were those in the Neu-
ropathology Department. Trevor and David took it 
in turns, several months at a time, to supervise my 
diagnostic work and I had the close assistance of 
the technicians in the preparation of the sections I 
needed to do this work. I liaised closely with the 
neurosurgeons and neurologists over the results. At 
times there was another trainee doing a project in 
the department or a visitor making use of the ma-
terial we had available for them to study. I remem-
ber particularly a very pleasant, recently retired, 
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Canadian professor of anatomy, Richard Saunders, 
who came to spend a few winters in Oxford with 
his wife to escape the worst of the winter in Nova 
Scotia. They had a son who was an Oxford Rhodes 
Scholar. Richard had an intimate knowledge of the 
structure of the hippocampus which he did his best 
to impart to me. It turned out to be useful 
knowledge when I became interested in Alz-
heimer’s disease. 
I made regular visits to local district general 
hospitals where I provided a diagnostic service on 
neurological post mortem cases. I discovered that 
histopathologists in these hospitals had to deal 
with quite a lot of neurological cases as the hospi-
tals had consultant neurologists working in them. 
This visiting service yielded many interesting cases 
from which I brought back to our department se-
lected samples for expert processing. I would then 
send reports on these cases back to the histo-
pathologists. 
Once or twice a year there were meetings of 
the UK neuropathology community. Trainee and 
consultant neuropathologists could apply to join 
the British Neuropathological Society, which organ-
ised these meetings, after they had delivered one 
sponsored paper or poster at one of the meetings. 
Some overseas neuropathologists also joined the 
Society. My first paper to the Society, sponsored by 
Trevor, described the work I had done on experi-
mental leprosy infection in the Anatomy Depart-
ment. It was interesting to get to know neuropa-
thologists working in other centres and to compare 
notes on our respective research projects. I found 
them to be a very congenial group. Collaboration 
with some of them became an important asset in 
devising some research projects for which more 
cases of a particular disease might be needed than 
were available in one centre. It was also helpful at 
times to be able to send a puzzling diagnostic spec-
imen to someone in another centre to obtain a 
second opinion on the diagnosis. 
Towards the end of my time as a registrar I 
made the acquaintance of a recently appointed 
consultant in geriatric medicine, Gordon Wilcock. 
Gordon had come to enquire if there might be 
someone interested in collaborating with him to 
study the neuropathology of dementia, particularly 
Alzheimer’s disease. He was himself interested in 
learning some neuropathology and he had many 
patients under his care in the geriatric medicine 
wards on whom, if they agreed, he had carried out 
a simple cognitive test to determine whether or not 
they had dementia. A considerable number of them 
had dementia but there were others who did not, 
including quite a number who had had strokes. If 
any of these patients subsequently died, and their 
next-of-kin was willing for a post mortem to be 
performed, we were able to see what abnormali-
ties there were in the brain that contributed to 
making them demented. It was known that in Alz-
heimer’s disease there were two distinct micro-
scopic abnormalities: the presence of plaques and 
tangles. Gordon and I wanted to see if we could 
relate either plaques or tangles (or both) to the 
presence of dementia in his cognitively tested pa-
tients. 
We had the impression that the distribution of 
tangles in Alzheimer’s disease affected parts of the 
brain that were becoming known to be anatomical-
ly linked together. We took to discussing the neu-
roanatomy of Alzheimer’s disease on Friday after-
noons with experts on these cortico-cortical and 
cortico-hippocampal connections, Drs Tom Powell 
and his former DPhil student, Carl Pearson. Tom 
had spent his career on meticulous studies of the 
cerebral cortex and was greatly pleased to find that 
some of his work might have relevance to an un-
derstanding of such an important disease as Alz-
heimer’s disease. From these discussions came a 
study of the detailed distribution of plaques and 
tangles in the different layers of the cerebral cor-
tex3. The findings fitted well with what was known 
of the manner in which one part of the cortex was 
connected to others and to the hippocampus. 
Those regions most closely linked to the hippocam-
pus had many tangles while those parts of the cor-
tex which were most remote from the hippocam-
pus had the fewest tangles. This work was my in-
troduction to trying to understand Alzheimer’s 
disease from a neuropathological perspective. 
Another influence in fuelling my new interest 
in dementia was a publication by a neurochemist at 
London’s Institute of Neurology, Dr David Bowen. 
In the mid-1970s, he published a paper showing 
that in post mortem brain specimens that had been 
frozen at -70◦C immediately after removal from the 
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body there were many enzymes whose activity 
could be reliably measured. He furthermore 
showed that in Alzheimer’s disease the enzyme, 
choline acetyl transferase, required for the synthe-
sis of acetyl choline, was deficient. A similar finding 
was reported from two other laboratories at about 
the same time. This paper was a real eye-opener 
for me. I had previously assumed that after death 
all enzyme activity would cease. Gordon and I had 
discussions with David about providing him with 
frozen brain samples from the patients Gordon had 
tested for cognition on the wards and we were 
soon adopting the policy of deep freezing one side 
of the brain for David’s studies and carrying out our 
microscopic studies on the other side. This led to a 
realisation that it is the burden of neurofibrillary 
tangles that is held within the brain that deter-
mines the extent of dementia in Alzheimer’s dis-
ease, much more so than the amyloid load4. I have 
watched with dismay the dominance of amyloid in 
thinking about Alzheimer’s disease and how to 
prevent it that has lasted for decades. Hopefully, 
now that may change5. 
Not long after we had set up this programme 
to study dementia, Gordon was offered a profes-
sorship in care of the elderly at Bristol University 
and left Oxford but there was an interested con-
sultant in geriatric psychiatry at the large Little-
more mental hospital near Oxford, Dr John Robin-
son, who was able to play a similar role in supplying 
cases of dementia, though he was not in a position, 
as Gordon had been, to supply cases that did not 
have dementia. 
This collaboration with clinicians in our re-
search on dementia was the first time I had had the 
opportunity to work directly with doctors looking 
after patients to devise a research strategy. Neuro-
pathologists are too remote from direct patient 
care to be in a position to recruit patients to a 
study themselves. Some neuropathologists devel-
oped interests in brain tumours that they could 
follow using the biopsy specimens they received. 
Others developed experimental models of diseases 
that could be studied alongside human post mor-
tem material. But I think the most valuable contri-
bution that clinical neuropathologists can make is 
to work closely with their clinical colleagues to re-
cruit patients into clinic-pathological studies of 
human disease. 
By the mid-1970s, I had acquired enough ex-
perience to take the Royal College of Pathologists 
examination in Histopathology slanted to Neuropa-
thology. The written examinations were taken in 
London and for the practical exam I was instructed 
to go to Glasgow. I remember casting my eye hasti-
ly over my notes on the long train journey to Glas-
gow and thinking that to be taking examinations at 
the age of 35 years was too old! Fortunately, I 
passed this last one and was then in a position to 
think about the next step in my career. For the sake 
of our children who were happily settled in schools 
in Oxford, I wanted to remain there but there was 
only one academic post in Neuropathology and 
that would be occupied by David Oppenheimer for 
another few years. One of my colleagues in the 
Histopathology Department made a most helpful 
move at this point. He wrote to the Medical Re-
search Council on my behalf and asked if there 
might be a prospect of getting support from this 
source to fund research for a few years in Oxford. 
An encouraging reply to this enquiry led to me ap-
plying for a Senior Clinical Fellowship from the 
Medical Research Council. 
Becoming a Senior Clinical Fellow 
I put together an application for this Senior 
Clinical Fellowship to study a disease that had long 
been of interest to me – herpes simplex encephali-
tis. This is a rare condition but one that had a con-
siderable mortality at that time and which I had the 
chance to study post mortem. There were several 
enigmatic aspects to this disease which intrigued 
me. It seemed to affect people of a wide range of 
ages in whom it developed quite unexpectedly. Yet 
it was caused by a virus that infected some 90% of 
people in some of whom it caused recurrent cold 
sores. Like its cousin, varicella-zoster virus, which I 
had already encountered, it had the capacity to lie 
latent in sensory ganglia (for this virus, usually the 
trigeminal ganglion, because it usually causes a 
facial infection) from which it could reactivate un-
der a range of conditions such as fever, exposure to 
strong sunlight or the common cold. What was the 
process by which it could occasionally cause a dev-
astating encephalitis? I knew I would be able to 
study the distribution of the virus in the brain using 
immunohistology and an anti-herpes simplex anti-
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body, and I had tissue from enough cases, which 
had survived for varying periods of time after dis-
ease onset, to enable me to try to piece together 
the pathological process. Armed with this intention 
I was lucky enough to get the Fellowship for 5 years 
at consultant level salary plus some part-time tech-
nical help and costs of consumables. 
This period of full-time research reinforced my 
passion for investigating brain diseases of which 
there seemed so many without an effective treat-
ment, in part a consequence of inadequate under-
standing of the disease process – hardly surprising 
given the complexity of the nervous system and the 
difficulty of accessing brain tissue during the course 
of many of these diseases. At the time, brain imag-
ing was still rudimentary compared with how it is 
today and the post mortem examination, for those 
diseases that were fatal, gave the best lead to in-
crease understanding. 
Herpes simplex encephalitis has a very intri-
guing distribution of damage in the brain with an 
emphasis on the temporal lobes but with the dam-
age usually asymmetrically distributed6. The focus 
of damage overlaps with that in Alzheimer’s dis-
ease with the hippocampus and sites connected to 
it badly affected. From my visits to the Anatomy 
Department to discuss Alzheimer’s disease with 
Tom Powell and Carl Pearson, I knew these areas 
had close connections with the olfactory system so 
I studied the olfactory bulbs in these cases of her-
pes simplex encephalitis because it seemed possi-
ble that the virus, with its propensity to travel 
along axons, might reach the brain along this route. 
I could indeed detect the virus there but the olfac-
tory bulbs were not as damaged as sites in the 
amygdala and piriform cortex to which the olfacto-
ry tracts projected. Thus it seemed possible that 
the virus reached the olfactory bulbs by moving 
centrifugally, not centripetally, perhaps from a site 
of latency within the brain, perhaps the hippocam-
pus. The asymmetry of damage to the temporal 
lobes, which was more marked in those dying early 
in the course of the disease, might be explicable if 
it reactivated from inside one hippocampus and 
then travelled to the contralateral one via anatomi-
cal connections between the two. 
To take this work further I teamed up again 
with Albert Tomlinson, the virologist who had 
helped me examine the case of herpes zoster. We 
developed a mouse model of herpes simplex en-
cephalitis and showed that inoculation of the face 
led to the virus ascending to the brain via both the 
trigeminal and olfactory routes and the develop-
ment of both brain stem and temporal lobe in-
flammation. Others have pursued the possibility 
that latent infection of the brain with herpes sim-
plex virus may predispose to the development of 
Alzheimer’s disease but the opportunity to further 
investigate the human acute encephalitis was lost 
on account of the fortunate development of an 
effective treatment which reduced the fatality of 
the disease and resulted in many people affected 
recovering at least partially. 
A change of direction? 
While I was intent on this research, my chil-
dren had grown into their teens and my husband 
was exploring the possibility of returning to Nigeria 
to provide medical care there. This posed a dilem-
ma for me. Should I abandon my neuropathological 
career and re-train in tropical medicine or could I 
carry on with my neuropathology in Oxford part-
time while taking periods of unpaid leave to join my 
husband in Nigeria during school terms when our 
two younger children were at boarding school? The 
other alternative - to pursue neuropathology in 
Nigeria, in the very remote region in which my hus-
band decided to set up a medical practice - would 
have been impossible. I was able to negotiate to 
carry on part-time in Oxford for the last part of my 
research project, working full-time while in Oxford 
and visiting Nigeria between times. Strange though 
such an arrangement might seem, it actually 
worked well and, by the time the research was 
completed, David Oppenheimer had retired, giving 
me the expectation that I might apply for his (now 
vacant) post. 
That expectation was thrown into confusion 
by the government of the day deciding to impose 
drastic cuts to university financial support. As a 
result, all re-filling of posts was frozen and many 
posts were lost. I remained in a form of profession-
al limbo with short-term Medical Research Council 
support lasting 3 months at a time until a new pro-
fessor, John Newsom-Davis, was appointed in the 
Clinical Neurology Department on the retirement 
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of the previous postholder. John offered to attempt 
to reinstate the lectureship in Neuropathology 
which had previously been held in the Cellular Pa-
thology Department, but only if it could be held in 
the Clinical Neurology Department. The post was 
rescued in this way and I was appointed to it on a 
part-time basis that allowed me to continue with 
my visits to Nigeria. 
My husband’s choice of where to establish his 
clinic was partly determined by his wish to live in a 
part of the country that is decidedly cooler than the 
rest. He hated the tropical heat of most of the 
country and he knew I would too. His clinic was 
established in a town, Gembu, on the Mambilla 
Plateau, some 1,500 metres high and not far from 
the Cameroon border which lies to the east of Ni-
geria. The countryside is made up of grass-covered 
hills, interspersed with deep, fertile, valleys and the 
climate is really perfect, with temperate, warm, 
sunny weather and abundant rainfall. The roads 
were rudimentary in the extreme and getting to the 
place took some 12-15 hours of uncomfortable 
land rover motoring after a domestic air flight to 
the nearest place with an airport, Yola. Over the 
years, a tarred road of sorts was created that 
mounted the steep escarpment to the plateau but 
it was soon full of potholes that were hardly ever 
repaired. 
Spending 2 months at a time in Gembu in the 
spring and autumn of each year became my routine 
for about 20 years from the early 1980s. Because I 
couldn’t continue with neuropathological research 
while I was away, I decided to turn my attention to 
writing about the diseases I was interested in. My 
aim was to inform those coming after me about 
what I had learnt so far. My first book was written 
with John Booss, a neurologist from Yale, who 
came to Oxford on a sabbatical to study multiple 
sclerosis. Together we wrote a book on viral en-
cephalitis7. To write my parts, I took piles of refer-
ences with me to read and digest in Gembu, mainly 
in the afternoons and evenings after I had helped in 
the mornings at my husband’s clinic. My offerings 
there were decidedly amateurish but one felt that 
in such a place, where medical care barely existed, 
one was justified in doing one’s best. Once I had 
gained a little confidence from seeing people re-
cover or, at worst, return the next day for a re-
think about the diagnosis, I thoroughly enjoyed this 
experience. With no diversions such as newspapers 
or television to occupy the time later in the day I 
was able to think and write without interruption, 
although, in the evenings, any activity had to be 
carried out by the dim illumination offered by a 
‘tilly’ light, fuelled by kerosene. 
To follow up after publication of Viral Enceph-
alitis, I approached David Oppenheimer, who had 
recently retired, to see if he would be willing to 
write a book on diagnostic neuropathology with 
me. I felt greatly honoured to have had much tui-
tion from David during my training. He was a truly 
inspiring person and I felt it would be good if other 
people could benefit from his teaching even if it 
had to be in the form of a textbook. I knew he 
wrote superbly so could convey his knowledge in 
that way. He thought about it and agreed to write a 
‘pamphlet’ in which we would divide up the topics 
evenly between us. He had kept the photographic 
slides that he had collected over his career so was 
able to make use of these and entered into the 
writing of the ‘pamphlet’ with enthusiasm. I con-
tinued to learn from him as we wrote and it was a 
complete pleasure, at the end of a working day 
when I was in Oxford, to visit him and his wife on 
my way home and to share the new text he had 
written during the day. I think he also enjoyed be-
ing able to extend his teaching of neuropathology 
in this way. The result was a textbook of nearly 400 
pages that was published as Diagnostic Neuropa-
thology8. 
The third book that I initiated was one on the 
neuropathology of dementia9, which was co-edited 
with my colleague James Morris, who had stepped 
into the post that Trevor Hughes had vacated when 
he retired. That all these three books went in to 2nd 
editions pleased me as it suggested they had found 
useful homes among those in the neuroscience 
community. 
By this time, a major longitudinal study of age-
ing and dementia, the Oxford Project to Investigate 
Memory and Dementia (OPTIMA,) had been started 
by David Smith, Professor of Pharmacology in Ox-
ford, and we were benefitting from the opportunity 
to study the brains of dementia sufferers and 
healthy elderly controls who had been followed up 
in a detailed way during life and had consented to 
donating their brain for research after their death. 
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This study grew slowly, as such longitudinal studies 
do, but we eventually collected over 500 brains 
that helped to increase understanding of dementia, 
and still continue to do so. 
Forging ahead 
Once I had been appointed to an academic 
position in neuropathology in the mid-1980s, I 
started to supervise graduate students who wished 
to study the brain and its diseases. I always insisted 
that students should have two co-supervisors be-
cause of the periods I spent in Nigeria and out of 
contact with the department. Two months was the 
maximum that I considered possible to remove 
myself from all the activities that go on in a de-
partment that has diagnostic, teaching and re-
search interests. Sometimes I would return to find 
a pile of problems to solve but usually everything 
had continued smoothly and I had the pleasure of 
hearing about the new findings that had emerged 
while I was away. Because of these periods of leave 
I kept my other absences from the department to a 
minimum which meant attending very few confer-
ences and meetings – a sacrifice that I was willing 
to make in return for the privilege of being able to 
continue with my professional work in my rather 
unusual personal circumstances. 
The department was expanding at this time 
(the late 1980s) with the arrival in Oxford of Profes-
sor Tim Crow, a psychiatrist with a deep interest in 
biological aspects of psychiatric disease, particular-
ly schizophrenia. We were able to expand into a 
new small laboratory and recruit an experienced 
technical manager and a small group of research 
students to work on psychiatric disease. We were 
also joined by a research group created by a local 
academic psychiatrist, Dr Paul Harrison. I was never 
in any doubt that study of the brain was needed as 
much to understand these diseases as it was for 
dementia and ageing and for neurological diseases. 
In the neuropathology department, I had wonder-
ful collaborations with psychiatrists as well as neu-
rologists and neurosurgeons. It seemed very odd to 
me that there was little direct communication be-
tween clinical neurologists and psychiatrists and 
little shared training for the two disciplines but this 
may be changing now. There were also superb op-
portunities in Oxford to collaborate and learn from 
neuroscientists in the basic science departments 
from which we benefitted enormously. 
A great boost to our research on schizophre-
nia came from the generous provision of a substan-
tial group of brains donated for research in Belfast, 
Northern Ireland. Professor Ingrid Allen, the senior 
neuropathologist in Belfast, and her colleague in 
psychiatry, Dr Steven Cooper, were instrumental in 
creating this initiative with Tim Crow. Tim had a 
fascinating hypothesis about schizophrenia: that it 
was somehow related to subtle differences in cere-
bral asymmetry, that differs normally between men 
and women, but which he thought might be dis-
turbed in those with schizophrenia. This led to our 
studies of the brain in schizophrenia being carried 
out having regard to sex and cerebral hemisphere 
side. We also studied the corpus callosum and oth-
er tracts that connect the two hemispheres. We 
found tantalising findings on this basis that seemed 
to indicate, among other things, that schizophrenic 
males have cerebral hemispheres more akin to 
normal females than occurs normally in males and 
vice versa for female schizophrenics. We should not 
have found these differences if we had studied 
schizophrenia without distinguishing between the 
sex of subjects whose brains we studied. Although 
it has become fashionable in psychology to down-
play differences in brain structure between males 
and females I think these differences are important 
and may have significant roles in psychiatric disease 
that we are not yet able to understand. 
While these attempts to understand psychiat-
ric disease were launched, we were also continuing 
to investigate dementia and ageing with the OPTI-
MA resource. A graduate student, Zsuzsa Nagy, 
who remained for a while in the department as a 
postgraduate research scientist, discovered that 
neurons expressed antigens indicating they had re-
entered the cell division cycle in elderly subjects. 
This discovery, which has been repeatedly con-
firmed by others, led to studies of lymphocytes and 
the suggestion that properties of these cells in cul-
ture might have diagnostic value for Alzheimer’s 
disease. Although this work has been followed up, 
we are still without a simple method of diagnosing 
this disease, particularly in its earliest phase, when 
symptoms are absent or minimal, but at the best 
time for any intervention to be made to slow or 
stop its development. 
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My interest in multiple sclerosis was re-ignited 
at about this time by two developments. The first 
was provoked by a paper that came out in The Lan-
cet linking episodes of clinical expression at the 
start and in relapse in multiple sclerosis to episodes 
of previous sinusitis. The author, Frederick Gay, 
was a general practitioner and he made his obser-
vations using general practitioner records. He 
thought it possible that bacterial antigens derived 
from microorganisms in the paranasal sinuses 
might reach the CNS compartment in some individ-
uals and lead to an immune response that created 
the demyelinating, inflammatory lesions typical of 
this condition. We worked together on this idea 
but, given its unfashionable nature at a time when 
most interest lay in viruses having a role in the dis-
ease (if, indeed, any foreign antigens were in-
volved), funding to make progress was hard to ac-
quire. The idea, however still has great attractions, 
in my opinion, and it is still being actively pursued. 
The second development that brought back 
my active interest in multiple sclerosis was applying 
immunohistology yet again but this time using an 
antibody to amyloid precursor protein as a marker 
of damaged axons. Although axons have long been 
known to be damaged in MS, the extent of that 
damage, its timing and its role in progression of the 
disease were little appreciated largely because 
there had been no sensitive method of assessing its 
extent. Being able to detect damaged axons with 
great sensitivity, which detection of amyloid pre-
cursor protein provided, changed this situation and 
when we applied the technique to multiple sclero-
sis lesions of differing age I was greatly surprised by 
the result. I had expected that we should see dam-
aged axons in chronic lesions which are common in 
progressive disease but it was actually in the most 
recent lesions that axon damage was most prolific10 
(Fig. 5). This was despite the fact that recent lesions 
are more common at earlier phases of the disease 
when recovery from relapses is common. Initially it 
seemed hard to understand how damage to axons, 
which we assumed was irreversible, was compati-
ble with a history of relapse followed often by re-
mission. This pattern of illness seemed more com-
patible with pathology that was reversible, likely 
demyelination and the inflammation that accom-
panied it. But we soon realised that because there 
is much redundancy in the CNS, progression of 
damage would only occur when a threshold of axon 
loss and other forms of neurodegeneration was 
reached, leaving room for recovery between epi-
sodes of inflammation before that point was ar-
rived at. 
 
 
Fig. 5. Graphs to illustrate the profile of axonal injury (APP 
stippled areas) and the number of macrophages (black areas) 
in a typical acute multiple sclerosis lesion (A), active chronic 
multiple sclerosis lesion (B) and chronic multiple sclerosis 
lesion (C). 
From ref. 10 
 
This reassessment of multiple sclerosis and, in 
particular, its neurodegenerative aspects, made me 
acutely aware of how progress in understanding 
disease depends on new techniques being applied 
to enable new knowledge to be acquired. The spec-
tacular developments in neuroimaging over the 
past few decades have enabled much progress to 
be made in understanding CNS diseases and this 
will continue. Nevertheless, there is still a place for 
pathological studies because these are still needed 
to penetrate to the cellular and molecular levels of 
change that accompany disease. Without 
knowledge at these levels rational treatment or 
prevention cannot be achieved. The new frontier 
relating to knowledge that has grown up in the last 
two decades is about genetics. Here there is such a 
wealth of new information that new ways of man-
aging data are needed but I remain convinced that 
it is the protein and other structural aspects of cells 
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that will provide the key answers to what happens 
to the state of the body in disease and, therefore, 
what can be done to remedy it. 
 
Fig. 6. Margaret M Esiri (2000) 
The future 
Along with new technical developments ena-
bling fresh knowledge to be acquired about dis-
ease, it is vital that there are new ideas. These arise 
from human imagination and ingenuity. Ideas can 
come to a researcher from all sorts of experiences 
and at any stage of their career but, in the long run, 
a steady supply of new research students with nov-
el ideas is essential. That is why I have been so for-
tunate in having a career in an outstanding univer-
sity in which tutors take extraordinary efforts to 
select the best students some of whom can then 
become the generators, along with newcomers 
from elsewhere, of the next wave of insights. They 
start off without the baggage of long indoctrination 
with the previous and current dogmas and bring 
creativity to a research team. Students that I have 
supervised have repaid my confidence in them in 
spades and I feel their hands are fully capable of 
taking forward the fields that came to fascinate me. 
The person I have kept in closest touch with is Ga-
briele DeLuca, now a consultant neurologist at Ox-
ford with a lively research group, who brings ener-
gy, creativity and flare to his research and teaching, 
making him an inspiration for yet another genera-
tion of young medical students and scientists. 
One thing writing a memoir brings home is the 
manner in which attitudes and knowledge reach 
you and which you, in turn, pass on to others. 
There is a social angle to all this, with an amplifying 
effect of teaching and example, that, at best, is 
inspiring and uplifting. 
At the age of 78, I still find it impossible to 
abandon my interests in neuropathology and I am 
incredibly lucky to have a department that still wel-
comes me into its fold. 
 
 
Fig. 7. Left: Margaret M Esiri, Right: A composite painting depicting the three buildings in which I worked as a neuropathologist: Rad-
cliffe Infirmary (left), St Hugh’s College (centre), John Radcliffe Hospital, West Wing (right). 
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